LAUREN SCOTT: Open Payments
NPI 1588201552 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 57 payments from 14 companies in 2025. Trend: 2023 $1,831 · 2024 $1,716 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $456 |
| Amgen Inc. | 11 | $160 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| GENZYME CORPORATION | 2 | $93 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Janssen Biotech, Inc. | 3 | $56 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| UCB, Inc. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $26 |
Products named: RINVOQ, SKYRIZI, SAPHNELO, KEVZARA, BENLYSTA, COSENTYX, TREMFYA, ENBREL.
Industry payments across MO — which companies pay providers there.
